📣 VC round data is live. Check it out!
- Public Comps
- Precipio
Precipio Valuation Multiples
Discover revenue and EBITDA valuation multiples for Precipio and similar public comparables like BGSF, Staffline Group, Gattaca, Dedicare and more.
Precipio Overview
About Precipio
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
Founded
1997
HQ

Employees
60
Website
Sectors
Financials (FY)
EV
$54M
Valuation Multiples
Start free trialPrecipio Financials
Precipio reported last fiscal year revenue of $24M and EBITDA of $1M.
In the same fiscal year, Precipio generated $11M in gross profit, $1M in EBITDA, and had net loss of ($363K).
Precipio P&L
In the most recent fiscal year, Precipio reported revenue of $24M and EBITDA of $1M.
Precipio is unprofitable as of last fiscal year, with gross margin of 45%, EBITDA margin of 6%, and net margin of (2%).
Financial data powered by Morningstar, Inc.
Precipio Stock Performance
Precipio has current market cap of $53M, and enterprise value of $54M.
Precipio's stock price is $29.81.
Precipio has an EPS (earnings per share) of $-0.20.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $54M | $53M | 0.0% | — | — | — | $-0.20 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPrecipio Valuation Multiples
Precipio trades at 2.3x EV/Revenue multiple, and 37.1x EV/EBITDA.
Precipio Financial Valuation Multiples
As of May 10, 2026, Precipio has market cap of $53M and EV of $54M.
Precipio has a P/E ratio of (146.6x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Precipio Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Precipio Margins & Growth Rates
In the most recent fiscal year, Precipio reported gross margin of 45%, EBITDA margin of 6%, and net margin of (2%).
Precipio Margins
Precipio Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Precipio Operational KPIs
Precipio's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Precipio Competitors
Precipio competitors include BGSF, Staffline Group, Gattaca, Dedicare, Peoplein, Freelancer, Wantedly, Administer, Ogunsen and eSense Human Resources.
Most Precipio public comparables operate across Recruitment & Staffing.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.4x | 0.4x | (5.2x) | — | |||
| 0.0x | 0.0x | 2.8x | 2.7x | |||
| 0.1x | 0.1x | 5.1x | 3.9x | |||
| 0.2x | — | 5.1x | — | |||
| 0.1x | 0.1x | 3.2x | 4.7x | |||
| 0.8x | 0.9x | 5.2x | 6.2x | |||
| 0.7x | 0.8x | 2.2x | — | |||
| 0.6x | 0.5x | 7.0x | 6.6x | |||
This data is available for Pro users. Sign up to see all Precipio competitors and their valuation data. Start Free Trial | ||||||
Precipio Funding History
Before going public, Precipio raised $2M in total equity funding, across 1 round.
Precipio Funding Rounds
Precipio M&A Activity
Precipio has acquired 1 company to date.
Last acquisition by Precipio was on October 13th 2016. Precipio acquired Transgenomic for undisclosed valuation.
Latest Acquisitions by Precipio
| Description | Transgenomic is a global biotechnology firm offering molecular diagnostics, genetic testing, and research services in cardiology, oncology, neurology, and mitochondrial disorders. Its divisions include clinical laboratories, pharmacogenomic services for drug trials, and diagnostic tools like the C-GAAP cardiac test. Serving over 50 countries, the company acquired Clinical Data's diagnostics in 2010 and operates from New Haven, Connecticut. |
| HQ Country | |
| HQ City | Omaha, NE |
| Deal Date | 13 Oct 2016 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Precipio acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Precipio
| When was Precipio founded? | Precipio was founded in 1997. |
| Where is Precipio headquartered? | Precipio is headquartered in United States. |
| How many employees does Precipio have? | As of today, Precipio has over 60 employees. |
| Is Precipio publicly listed? | Yes, Precipio is a public company listed on Nasdaq. |
| What is the stock symbol of Precipio? | Precipio trades under PRPO ticker. |
| When did Precipio go public? | Precipio went public in 2000. |
| Who are competitors of Precipio? | Precipio main competitors include BGSF, Staffline Group, Gattaca, Dedicare, Peoplein, Freelancer, Wantedly, Administer, Ogunsen, eSense Human Resources. |
| What is the current market cap of Precipio? | Precipio's current market cap is $53M. |
| What is the current revenue of Precipio? | Precipio's last fiscal year revenue is $24M. |
| What is the current EV/Revenue multiple of Precipio? | Current revenue multiple of Precipio is 2.3x. |
| Is Precipio profitable? | No, Precipio is not profitable. |
| How many companies Precipio has acquired to date? | As of May 2026, Precipio has acquired 1 company. |
| What was the largest acquisition by Precipio? | None of the M&A deals Precipio has completed have disclosed valuations. |
| What companies Precipio acquired? | Precipio acquired Transgenomic. |
| In how many companies Precipio has invested to date? | Precipio hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Precipio
Lists including Precipio
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
